Litcius/Paper detail

Use of Active Surveillance vs Definitive Treatment Among Men With Low- and Favorable Intermediate–Risk Prostate Cancer in the US Between 2010 and 2018

Bashir Al Hussein Al Awamlh, Daniel A. Barocas, Alec Zhu, Jeffrey J. Tosoian, Lee Ponsky, Serban Negoita, Jonathan E. Shoag

2023JAMA Internal Medicine28 citationsDOIOpen Access PDF

Abstract

This cross-sectional study of data from the Surveillance, Epidemiology and End Results database assesses temporal trends in the use of active surveillance and watchful waiting vs definitive treatment in men with low- and favorable intermediate–risk prostate cancer in the US between 2010 and 2018.

Topics & Concepts

Watchful waitingMedicineProstate cancerSurveillance, Epidemiology, and End ResultsEpidemiologyCancerGynecologyInternal medicineCancer registryProstate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchAdvanced Causal Inference Techniques